Multisite Phosphorylation Modulates the T Cell Receptor ζ-Chain Potency but not the Switchlike Response  by Mukhopadhyay, Himadri et al.
ArticleMultisite Phosphorylation Modulates the T Cell
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Oxfordshire, United Kingdom; and 3Department of Mathematics, University of California-Irvine, Irvine, CaliforniaABSTRACT Multisite phosphorylation is ubiquitous in cellular signaling and is thought to provide signaling proteins with addi-
tional regulatory mechanisms. Indeed, mathematical models have revealed a large number of mechanisms by which multisite
phosphorylation can produce switchlike responses. The T cell antigen receptor (TCR) is a multisubunit receptor on the surface of
T cells that is a prototypical multisite substrate as it contains 20 sites that are distributed on 10 conserved immunoreceptor tyro-
sine-based activation motifs (ITAMs). The TCR z-chain is a homodimer subunit that contains six ITAMs (12 sites) and exhibits a
number of properties that are predicted to be sufficient for a switchlike response. We have used cellular reconstitution to sys-
tematically study multisite phosphorylation of the TCR z-chain. We find that multisite phosphorylation proceeds by a nonsequen-
tial random mechanism, and find no evidence that multiple ITAMs modulate a switchlike response but do find that they alter
receptor potency and maximum phosphorylation. Modulation of receptor potency can be explained by a reduction in molecular
entropy of the disordered z-chain upon phosphorylation. We further find that the tyrosine kinase ZAP-70 increases receptor
potency but does not modulate the switchlike response. In contrast to other multisite proteins, where phosphorylations act in
strong concert to modulate protein function, we suggest that the multiple ITAMs on the TCR function mainly to amplify subse-
quent signaling.INTRODUCTIONProtein phosphorylation is a ubiquitous mechanism of signal
transduction that is regulated by the opposing actions of
kinases and phosphatases (1,2). Failure to regulate phos-
phorylation can lead to a number of abnormal cellular phe-
notypes, such as constitutive cell growth, which is the case
in many cancers (1,3). The majority of eukarotyic proteins
are phosphorylated on more than one site (4,5), raising the
possibility that multisite phosphorylation may confer an
additional regulatory mechanism (6,7).
A well-known regulatory mechanism is a switchlike
response, whereby the phosphorylation state of a protein
can be highly sensitive to the concentrations of its modi-
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creativecommons.org/licenses/by/4.0/).focused on understanding whether multiple phosphorylation
sites on a single substrate can confer switchlike responses.
Mathematical models have shown that switchlike responses
can be produced by a number of mechanisms that rely on
multiple phosphorylation sites, such as substrate seque-
stration (8), nonessential sites (9), local concentrations
(10), independent binding sites (11), membrane-anchoring
(diffusion-limited reactions) (12), entropic mechanisms
(13), binding of effector molecules (14), cooperativity be-
tween sites, or site-specific enzymatic rates (15), and other
mechanisms reviewed elsewhere (2,6,7). The key difference
between the models lies in the assumptions about how the
sites are modified. For example, a switchlike response can
be produced when the modifying enzymes phosphorylate
the substrate in a precise sequence but not when modifica-
tion is random (Fig. S1 in the Supporting Material). Despite
extensive mathematical studies, there are few experimental
studies aimed at a systematic investigation of multisite
phosphorylation.
The T cell antigen receptor (TCR) on the surface of
T cells is a prototypical multisite substrate (16). T cells
Multisite z-Chain Phosphorylationrely on the TCR to recognize antigens, in the form of pep-
tides bound to major histocompatibility complexes, on the
surfaces of antigen-presenting cells. Ligation of the TCR
by peptides bound to major histocompatibility complexes
can trigger a large signal transduction cascade in T cells
that may lead to a number of functional responses, such as
proliferation, differentiation, and the secretion of effector
cytokines (17,18). The T cell response is of crucial impor-
tance in the elimination of infections and pathologies, and
the ability to harness this response is a central objective in
immune-based therapies (19).
The TCR is a multisubunit receptor that contains two
ligand binding chains that associate with six signaling
chains that collectively contain 20 phosphorylation sites.
These sites are distributed on 10 immunotyrosine-acti-
vated-based motifs (ITAMs) with consensus sequence
YXX[L/I]X6–9YXX[L/I], where X is any amino acid (20).
While four of the signaling chains each contain one
ITAM, the T cell receptor z-chains, which form a homo-
dimer by a disulfide bond in the transmembrane domain,
each contain three ITAMs (or six ITAMs across the dimer).
These sites are phosphorylated by the membrane-anchored
tyrosine kinase Lck and Fyn and dephosphorylated by
the transmembrane phosphatases CD148 and CD45. When
both tyrosines in an ITAM are phosphorylated they generate
docking sites for the tandem SH2 domains of the cytosolic
tyrosine kinase ZAP-70. Bound ZAP-70 can phosphorylate
tyrosines on other substrates that initiate the signal transduc-
tion that may lead to T cell activation (17).
Given that both kinases and phosphatases are constitu-
tively active in resting T cells (16,21), it is thought that
the phosphorylation state of the TCR is tightly regulated.
This is underlined by the observation that even a single
TCR ligand is sufficient to activate T cells (22).
A number of the multisite phosphorylation mechanisms
that produce switchlike responses discussed above may be
applicable to the T cell receptor z-chain. The z-chain has
been shown to be sequentially phosphorylated (23,24),
which is sufficient to produce switchlike responses
(Fig. S1). Moreover, it contains nonessential sites because
even a single phosphorylated ITAM is sufficient to recruit
and activate ZAP-70, it has the potential to be sequestered
in the membrane when fully dephosphorylated (25), and
components of the signaling module are membrane-
anchored. We have also used a mathematical model to
show that differential binding affinities of ZAP-70 to each
of the z-chain ITAMs combined with sequential phosphory-
lation can produce switchlike responses (14).
In this work, we have investigated how the phosphoryla-
tion state of the z-chain is regulated by changes to the
kinase/phosphatase ratio as the number of phosphorylation
sites is modified. To do this, we performed cellular reconsti-
tution of 21 distinct signaling modules that include different
combinations of wild-type or mutant forms of the TCR
z-chain, Lck, CD148, and ZAP-70. By reconstitutingz-chains with all combinations of ITAM mutants, we found
no evidence for sequential phosphorylation, and surpris-
ingly, we found that phosphorylation sites did not modulate
the switchlike response but did modulate receptor potency
and maximum phosphorylation. We show that a phosphory-
lation-dependent enhancement in the binding rate of the
enzymes can explain these observations and that a molecu-
lar mechanism that is consistent with such an enhance-
ment is a disorder-to-order transition of the z-chain upon
phosphorylation.MATERIALS AND METHODS
Plasmids
All sequences used in this study were of murine origin unless otherwise
stated. TCR z-chain variants were generated as previously described in
Choudhuri et al. (26). Briefly, the transmembrane and cytoplasmic domains
of mouse TCR z-chain were cloned in frame with the extracellular domains
of rat CD2 in the mammalian expression vector pcDNA3.1(þ). For each
ITAM mutant, both ITAM tyrosines were mutated to phenylalanine. Lck
was cloned into the mammalian expression vector pEF3 as a constitutively
active Y505F-variant (27). An SH2-binding mutant, Lck(R154K), was
generated by QuikChange PCR (Agilent Technologies, Santa Clara, CA).
Ectodomain-truncated CD148, encoding the last two C-terminal fibronectin
type III, transmembrane, and catalytic domains, as well as an extracellular
FLAG-tag, was generated as previously described in Cordoba et al. (28),
and cloned in the expression vector pcDNA3.1(þ). ZAP-70 was cloned
into a pcDNA3.1(þ) vector, and the low activity variant (ZAP-70*)
containing the SH2-binding mutations, R41K and R190K, as well as the
catalytically dead mutation, K368A, was generated by QuikChange PCR
(Agilent Technologies).Cell culture and transfection
HEK 293T cells were cultured at 37C and in a 10% CO2 in DMEM con-
taining 10% fetal bovine serum. A day before transfection, cells were
seeded to reach 70% confluence, and a single 175 cm2 flask was transiently
transfected for each experimental condition. For experiments including
only Lck, CD148, and TCR z-chain variants, 8 mg of each plasmid
(24 mg total) was complexed with 24 mg of branched-chain PEI (polyethy-
lenimine, average Mw 25,000; Sigma-Aldrich, St. Louis, MO) in 0.9 mL
serum-free medium for 10 min, before dropwise addition to cells in
serum-free medium. An additional 25 mg of ZAP-70 DNA and 25 mg of
PEI was included in transfection mixtures in experiments containing
ZAP70. Cells were incubated at 37C for 4 h before transfection medium
was replaced with complete medium supplemented with fetal bovine
serum. Cells were harvested after 24 h by gentle shaking, centrifuged,
and resuspended in fresh serum-free medium at an appropriate density
for assay.Pervanadate treatment of transfectants
Basal kinase/phosphatase balance was disrupted by inhibition of phospha-
tase activity with a serial dilution of pervanadate. Pervanadate was gener-
ated immediately before the assay by incubating 10 mM sodium
orthovanadate with 0.7% H2O2 at room temperature for 10 min. H2O2
was inactivated by the addition of 20 mg/mL catalase at room temperature
for 10 min. A 24-step, 1.25-fold serial dilution of pervanadate was made up
in serum-free medium starting at 1 mM. Harvested transfectants were
plated at 300,000 cells per well in 96-well assay plates in a volume of
60 mL/well and treated with 60 mL/well pervanadate serial dilutions forBiophysical Journal 110, 1896–1906, April 26, 2016 1897
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cells were lysed by adding 120 mL/well lysis buffer containing 2% Nonidet
P-40 substitute (Roche, Indianapolis, IN), Mammalian Protease Inhibitor
Cocktail (Sigma-Aldrich), and 250 mM sodium orthovanadate in TBS
(20 mM Tris, pH 7.5, 150 mM NaCl). Cellular debris was removed by
centrifugation and lysates were transferred to wells of previously prepared
immunosorbent capture plates.Immunosorbent assay of TCR z-chain
phosphorylation
TCR z-chain phosphorylation was quantified in immunosorbent assay by
capturing chimeric TCR z-chain with anti-rat CD2 antibody and detecting
phosphorylation with anti-phosphotyrosine antibody. A day before assay,
MaxiSorp flat-bottom 96-well plates (Nalge Nunc, Rochester, NY) were
coated overnight at 4C with 100 mL/well anti-rat CD2 antibody (AbD
Serotec) at 0.7 mg/mL in carbonate-bicarbonate buffer, pH 9.6. On the
day of the assay, capture antibody was decanted and wells were blocked
with 200 mL 1% bovine serum albumin in TBS for 1 h at room temperature.
Plates were washed three times with TBS-T buffer (TBS containing 0.05%
TWEEN-20). Cleared saturating amounts of lysate was transferred to plates
and TCR z-chain captured for 2 h at 4C. Lysate was decanted and plates
were washed 6 times with TBS-T. Phosphorylation was probed by addition
of 100 mL/well of biotinylated anti-phosphotyrosine antibody (clone pY20;
BioLegend, San Diego, CA) at 1 mg/mL, and plates were incubated for 1 h
at room temperature. Plates were subsequently washed 3 times with TBS-T.
Biotinylated antibody was probed with 100 mL/well of 0.1 mg/mL IRDye
800CW-streptavidin (LI-COR Biosciences, Lincoln, NE) for 1 h at room
temperature. Plates were washed three times with TBS-T, dried, and fluo-
rescence-detected by scanning plates in an Odyssey Sa Infrared Imaging
System (LI-COR).Flow cytometry
Transfectants were blocked by incubating 1 106 cells for 15 min on ice in
100 mL 1% PBS-A (albumin in phosphate-buffered saline). Surface
antigens were stained by incubating for 1 h on ice with 1 mg/ml FITC-con-
jugated anti-FLAG antibody (Sigma-Aldrich) and 1 mg/mL phycoerythrin-
conjugated anti-rat CD2 (AbD Serotec, Kidlington, Oxfordshire, UK) in
100 mL PBS-A. Cells were washed three times in PBS and fixed with 4%
paraformaldehyde in PBS for 15 min at room temperature. Cells were
washed three times in PBS and permeabilized in 0.1% saponin (Sigma-Al-
drich) in PBS-A. Intracellular antigens were stained by incubating for 1 h at
room temperature with 1 mg/mL Alexa Fluor 647-conjugated anti-mouse
Lck (BD Biosciences, San Jose, CA) and 1 mg/mL Pacific Blue-conjugated
anti-mouse ZAP-70 (Thermo Fisher Scientific, Guilford, CT) in 100 mL
PBS-A. Cells were washed three times with PBS and analyzed using a
FACScan flow cytometer (Becton Dickinson, Franklin Lakes, NJ).Curve fitting, normalization, and statistical
analyses
The steady-state phosphorylation profiles were fit to a logarithmic Hill
function in Prism (GraphPad Software, La Jolla, CA), that produces esti-
mates of Emin and Emax, which correspond to the minimum and maximum
values, respectively, log10(EC50), which is the logarithmic value of the ki-
nase/phosphatase that yields half of the maximal response (otherwise
known as potency), and n, which is the Hill number that determines the de-
gree of the switchlike response (also known as the sensitivity).
We used an index module (wild-type z 123) as our standard curve so
that experimental data can be averaged across different days. This normal-
ization was performed by (1) dividing the response for each module by the
value of Emax for the index module and (2) by subtracting the pervanadate1898 Biophysical Journal 110, 1896–1906, April 26, 2016concentration series on a log-scale (x axis) by the value of EC50 for the
index module. Fitted Hill numbers were normalized to the value of the in-
dex module.
All statistical analyses were carried out on normalized averaged quanti-
ties using a t-test in Prism (GraphPad Software). Given that the Hill number
and log10(EC50) of the index module was 1 and 0, respectively, we used a
t-test to determine whether the corresponding values for the group of single
ITAM mutants (zX23, z1X3, and z12X) or the double ITAM mutants
(z1XX, zX2X, and zXX3) differed from these values. An unpaired t-test
was used to compare between the group of single and double ITAM
mutants.RESULTS
Cellular reconstitution of multisite
phosphorylation of the T cell receptor z-chain
To study the effects of multiple phosphorylation sites on the
T cell receptor z-chain, we reconstituted four components in
various combinations (Fig. 1 A). Thewild-type substrate was
a chimera consisting of the z-chain transmembrane and cyto-
solic domains but with the extracellular domain of rat CD2
(previously used as a simplified receptor (26)). The wild-
type kinase was Lck with a point mutation to a negative
regulatory tyrosine (Y505F) that renders the kinase con-
stitutively active. The wild-type phosphatase was CD148
with a truncated extracellular domain, which was previously
shown to have higher expression (28). Lastly, we have used
wild-type ZAP-70 in a number of experiments.
Combinations of the wild-type components or mutant
variants were transfected into HEK293 cells (Fig. 1 B),
which comprise a nonhematopoietic human cell line that
is not expected to express any of the endogenous T cell re-
ceptor proximal signaling proteins (29). We found that
expression peaked 24 h posttransfection (not shown), and
therefore all experiments were performed at this time point.
Using a k-means clustering algorithm, we found that cells
were readily classified into two distinct populations that
were either positive for all three components or were nega-
tive for all three components (Fig. 1 B). Moreover, compo-
nent expression in the positive population was correlated
(Fig. S2), which has been previously shown to be the case
in transfections of HEK293 cells (30).
To determine the total phosphorylation profile of the
z-chain, the cells were treated with a titration of the tyrosine
phosphatase inhibitor pervanadate for 30 min before the
z-chain was captured using an anti-CD2 antibody and
phosphorylation detected using an anti-phosphotyrosine
antibody (Fig. 1 C). We found limited phosphorylation
without pervanadate treatment and moreover, treatment
with the Lck inhibitor PP2 did not lead to detectable reduc-
tion in phosphorylation (not shown), suggesting that CD148
dominates over Lck basally. Given that HEK293 cells are
expected to have endogenous tyrosine kinases and phospha-
tases, we determined their contribution by transfecting in
the substrate with only Lck or only CD148. Although we
observe dephosphorylation in the absence of exogenous
AC D
B
FIGURE 1 Cellular reconstitution of multisite
phosphorylation of the T cell receptor z-chain.
(A) Schematic of reconstituted signaling proteins.
The substrate is a CD2-TCRz-chain chimera that
contains six phosphorylation sites distributed on
three ITAMs (orange) that dimerizes as a result
of a disulfide bond in the z-chain transmembrane
domain (i.e., the substrate is a receptor dimer that
contains 12 phosphorylation sites). The substrate
is phosphorylated by the membrane-anchored ki-
nase Lck and dephosphorylated by the transmem-
brane phosphatase CD148. The cytosolic kinase
ZAP-70 can bind to phosphorylated ITAMs by
SH2 domains. (B) Combinations of these compo-
nents were transfected into the nonhematopoietic
HEK293 cell line and molecular expression was
detected with flow cytometry 24 h posttransfection.
A k-means clustering algorithm classified the cells
as either positive (red, 25%) or negative (blue,
75%) for transfected components (see Fig. S2 for
two-dimensional projections). (C) Cells trans-
fected with the indicated components were incu-
bated with increasing concentrations of the
tyrosine phosphatase inhibitor pervanadate for
30 min (x axis) before total phosphorylation of
the z-chain was determined (shaded rectangle
highlights the specificity range). (D) Phosphoryla-
tion time course for reconstitution of Lck, CD148,
and z-chain indicates that steady-state phosphory-
lation is achieved by ~15–20 min. See Materials
and Methods for experimental details. To see this
figure in color, go online.
Multisite z-Chain PhosphorylationCD148 or phosphorylation in the absence of exogenous Lck,
a large range exists where phosphorylation is regulated
primarily by exogenous Lck and CD148 (shaded
region, Fig. 1 C). Moreover, a timecourse revealed that
by ~15–20 min, the system has come to steady state
(Fig. 1 D).Multisite phosphorylation of the T cell receptor
z-chain modulates potency but not the switchlike
response
To determine the effects of multiple phosphorylation sites,
we reconstituted signaling modules where the number of
z-chain ITAMs is modified. We reconstituted Lck, CD148,
and either the wild-type TCR z-chain, z-chain with one
ITAM mutated (zX23, z1X3, and z12X), or z-chain with
two ITAMs mutated (z1XX, zX2X, and zXX3), where X in-
dicates that the two ITAM tyrosines have been mutated to
phenylalanine (Fig. 2 A).
As expected, a reduced ITAM number led to a reduced
maximum phosphorylation by ~1/3 per mutated ITAM.
The observation that the maximum phosphorylation de-
pends on the number of ITAMs, but not their identity,
suggests that a strict sequential mechanism of phosphoryla-
tion is unlikely to be operating. Rather, it is more likely thatz-chain phosphorylation follows an unstructured random
modification mechanism.
To determine the effects of multisite phosphorylation on
potency and the switchlike response, we fit a Hill function
to the phosphorylation profile to determine EC50 (potency)
and the Hill number (switchlike response). We found no
significant difference in the Hill number between the wild-
type z-chain, which as a dimer contains 12 phosphorylation
sites, and z-chains with ITAM mutations (Fig. 2 B). This
observation is also consistent with a random mechanism
of phosphorylation because, as discussed in the introduc-
tion, a sequential mechanism predicts that the switchlike
response will be modulated by the number of sites (Fig. S1).
While the advantage of the cellular reconstitution system
used here is that it maintains a normal cellular environment,
a key drawback is that chemical inhibitors must be used to
perturb the kinase-to-phosphatase balance. We have
observed absolute Hill numbers near 4 but we are unable
to rule out the possibility that these large Hill numbers
were a result of a nonlinear relationship between the con-
centration of inhibitor and the concentration of active phos-
phatase. Therefore, we confined our analysis to changes in
the Hill number (and other parameters) by reporting normal-
ized parameter values as the number of phosphorylation
sites is modified (see Materials and Methods).Biophysical Journal 110, 1896–1906, April 26, 2016 1899
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Mukhopadhyay et al.We observed a positive correlation between receptor po-
tency and the number of sites (Fig. 2C). This effect is not pre-
dicted by the standard models of multisite phosphorylation
where potency often remains unchanged as the number of
sites changes (Fig. S1). A simple (and trivial) explanation
for the modification in potency is that Lck and/or CD148
have different binding affinities or catalytic rates for each
ITAM. However, this explanation can be ruled out by the
observation that the phosphorylation profile of the three
z-chain constructs with only a single intact ITAM (z1XX,
zX2X, and zXX3) is similar, implying that both enzymes
are equally efficient at modifying each of the three ITAMs.
We conclude that it is the juxtaposition ofmultiple phosphor-
ylation sites (or ITAMs) in the wild-type z-chain configura-
tion that elicits a cooperative effect that increases potency.
To rule out that the differences in the phosphorylation
profiles are a result of differences in molecular expression,
we performed flow cytometry for every reconstituted
signaling module. We found that the percent of cells positive
for the three components and the expression levels of the
three components in the seven reconstituted modules were
similar (Figs. 2 D and S4). Moreover, we did not find any
significant correlations between expression level and param-
eters extracted from the phosphorylation profiles (not1900 Biophysical Journal 110, 1896–1906, April 26, 2016shown). We also found that the phosphorylation kinetics is
similar for ITAM mutants (Fig. S3).
Given that Lck contains an SH2 domain that can interact
directly with phosphorylated sites on the z-chain, we
wondered whether this domain could explain the observed
changes in potency. This recruitment could increase the
local concentration of Lck in the vicinity of the z-chain lead-
ing to enhanced efficiency of phosphorylation, which would
be greatest for wild-type z that contains the largest number
of sites. We introduced a point mutation to the Lck SH2
domain that is known to abolish binding (Lck-R154K) and
performed the reconstitution experiments on all seven
z-chain mutants. We found that the observed changes in
potency persisted, suggesting that the SH2 domain of Lck
is not responsible for increased potency (Fig. S5).ZAP-70 modulates T cell receptor z-chain potency
but not the switchlike response
We have previously used a mathematical model to show that
ZAP-70 can produce increases in both potency and the
switchlike response of the T cell receptor z-chain (14).
The predicted increase in the switchlike response was
critically dependent on sequential phosphorylation and on
Multisite z-Chain PhosphorylationZAP-70 binding to the three z-chain ITAMs with different
affinities, as previously reported in Love and Hayes (20)
and Isakov et al. (31). We therefore assessed the effects of
ZAP-70 on multisite z-chain phosphorylation.
We first compared the effects of ZAP-70 on the wild-type
z-chain by reconstituting Lck, CD148, and z-chain with
either wild-type ZAP-70 or a low activity ZAP-70 with in-
activating point mutations to the SH2 and catalytic do-
main(s) (ZAP-70*). These two domains are known to
favor phosphorylation; the SH2 domains can bind with
high affinity to phosphorylated ITAMs protecting them
from dephosphorylation and the catalytic domain may be
important to directly phosphorylate ITAM tyrosines. We
compare ZAP-70 with ZAP-70* to control for the total pro-
tein load imposed on the HEK293 cells by reconstitution.
Comparing the phosphorylation profiles of ZAP-70 and
ZAP-70* revealed the expected increase in potency but no
change to the switchlike response was observed (Fig. 3,
A–C), which is consistent with a recent report from Hui
and Vale (32). This result is also consistent with our previ-
ous theoretical prediction that ZAP-70 will not enhance
the switchlike response if the z-chain is modified by a
nonsequential random mechanism (14).
We next examined the contribution of each ITAM to the
ZAP-70-mediated increase in potency observed for the
wild-type z-chain. We reconstituted Lck, CD148, andζ123 + ZAP-70*
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observed, as before, no trend in the Hill number but a signif-
icant increase in potency with the number of phosphoryla-
tion sites. Importantly, we did not observe any differences
in potency within the z-chain group that contained two
ITAMs or within the z-chain group that contained one
ITAM, suggesting that ZAP-70 binds all z-chain ITAMs
in vivo with similar affinities. As before, we examined the
expression of all components to ensure that any differences
in the phosphorylation profiles were not a result of differ-
ences in molecular expression (Figs. S6 and S7).
In summary, ZAP-70 enhances the phosphorylation
potency of the TCR z-chain but does not alter the switchlike
response. Moreover, the correlation between the potency
and the number of phosphorylation sites observed in the
absence of ZAP-70 is maintained in its presence.Phosphorylation-dependent binding rates are
sufficient to explain the modulation of potency
by multisite phosphorylation
We have found a correlation between the number of phos-
phorylation sites or ITAMs with receptor potency that
cannot be explained by standard multisite phosphorylation
models (see Discussion). Moreover, the observation that
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Mukhopadhyay et al.ITAM mutant z-chains exhibited similar profiles indicates
that Lck and CD148 modify each ITAM with similar effi-
ciencies ruling out a trivial explanation for the enhanced
potency. We therefore hypothesized that the number of
phosphorylated ITAMs, independent of their specific iden-
tity, determines the rate of enzymatic modification.
We formulated a mathematical model that includes the
six ITAMs on the z-chain dimer (Fig. 4 A). Because we
do not have data relating to the effect of individual tyrosines
in an ITAM we have coarse-grained the two tyrosines of
each ITAM into an effective single site. We model a phos-
phorylation-dependent enhancement (or priming) of enzy-
matic efficiencies by enhancing kon for both enzymes with
increasing levels of z-chain phosphorylation. To do so, we
introduce a new parameter, l, which is the fold increase in
the on-rate per ITAM phosphorylation so that after
all ITAMs are phosphorylated the on-rate is increased by
lmax ¼ l6. Because all calculations are in the steady state,
we found similar results if enhancement is applied to koff
or kcat (not shown).
Computations with the mathematical model for l ¼ 3 (or
lmax ¼ 729) produced changes in potency without large dif-
ferences in the Hill number (Fig. 4 B). The value of l that
can reproduce these results was not unique because a param-
eter scan revealed a region of l kon space that is consistent
with changes in potency without changes in the Hill number
(Fig. S8). We found that the changes in potency can be re-
produced with a sufficiently large kon when l ¼ 1, but in
this limit there was residual phosphorylation that we did
not observe in our experimental data (Fig. S8 A). Therefore,
we conclude that a phosphorylation-dependent enhance-A
B
1902 Biophysical Journal 110, 1896–1906, April 26, 2016ment is the most likely explanation for the correlation be-
tween the number of ITAMs and receptor potency.
We next sought a plausible molecular mechanism that can
be responsible for the phosphorylation-dependent enhance-
ment. It has been previously proposed that molecular en-
tropy may be reduced by phosphorylation of disordered
amino-acid chains (33). In this model, the flexible disor-
dered amino-acid polymer can adopt many configurations
when free, but the binding of a catalytic domain reduces
the number of configurations and therefore an entropic pen-
alty to binding is incurred. This penalty can be substantially
reduced if phosphorylation decreases the number of config-
urations of the free polymer.
Given that the dimeric z-chain is predicted to be disor-
dered based on the sequence of its cytoplasmic chain (deter-
mined using established predictions algorithms (34,35)), we
used a polymer model to determine an upper bound on the
maximum fold-increase in the on-rate (lmax). The model in-
cludes the z-chain dimer anchored to the plasma membrane
with each polymer in the dimer, modeled as a freely jointed
chain with variable number of segments but a fixed overall
length. The length of each segment is known as the Kuhn
length (36). To calculate an upper bound for lmax, we
compare the probability that the catalytic domain of an
enzyme can bind the fully dephosphorylated z-chain
(maximum disorder) to a hypothetical situation where the
z-chain is completely ordered (i.e., exists in a single state
where there is no entropic penalty to bind) as a result of
maximum phosphorylation (Fig. 5 A).
There are two factors that determine lmax in the model:
the catalytic domain size and the Kuhn length. LargerFIGURE 4 A phosphorylation-dependent en-
hancement in enzymatic efficiencies is sufficient
to explain experimental results. (A) Multisite phos-
phorylation model showing the transitions between
the concentration of phosphorylated substrate on
the indicated number of ITAMs that is mediated
by the kinase (E) and the phosphatase (shown
as F). The model includes a fold-enhancement in
the on-rate (l) that is proportional to the number
of phosphorylated ITAMs with the maximum in-
crease lmax ~ l
6. (B) Phosphorylation profiles for
a 6-ITAM (z), 4-ITAM (zX), and a 2-ITAM
(zXX) substrate calculated using l ¼ 3 (lmax ¼
729) showing the potency and Hill numbers. See
the Supporting Material for computational details.
To see this figure in color, go online.
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FIGURE 5 A phosphorylation-dependent en-
hancement in the on-rate can arise from a disor-
der-to-order transition. (A) A polymer model of
the z-chain predicts that binding of the kinase (or
phosphatase) is impeded by entropic disorder
(left) and, if phosphorylation imposes local order,
this impedance will be reduced when the substrate
is phosphorylated with the maximal reduction
occurring when the substrate is fully phosphory-
lated (right). Larger catalytic domains will incur
a larger entropic penalty of binding. (B) The degree
of disorder is determined by the number of seg-
ments whose length is known as the Kuhn length.
(C) Heat map showing lmax for different segment
numbers (y axis) and for different ratios of the
catalytic domain radius to Kuhn length (x axis).
(D) Comparison of maximal enhancement over
the Kuhn length (or persistence length) when the
enzymatic binding site is at the center of the
z-chain (blue) or at the membrane-distal tyrosine
at position 152 (red). A Kuhn length of ~0.5 or
~2 amino acids corresponds to lmax ~ 700. Black
line in (C) corresponds to parameter range in (D).
See Materials and Methods for computational de-
tails. To see this figure in color, go online.
Multisite z-Chain Phosphorylationcatalytic domains will incur a larger entropic penalty
(increasing lmax) and smaller Kuhn lengths increase the
basal number of configurations (increasing lmax) (Fig. 5,
A and B). We therefore generated a heat map showing
lmax when these parameters are varied (Fig. 5 C) and also
show a specific slice of the heat map for clarity (Fig. 5 D).
When the Kuhn length is 0.3 nm (or approximately the
length of the Ca–Ca bond), we find that lmax z 8000;
whereas lmax z 700 (used in the phosphorylation model
above) can be found when the Kuhn length is 0.5 nm, which
is consistent with the flexibility previously reported for
polypeptide chains (37).
These calculations are based on the enzyme catalytic
domain interacting with a test tyrosine at the center of the
chain, but we have also performed the calculations with a
test tyrosine at position 152, which is the most distal tyro-
sine for murine z-chain, finding only a weak dependence
on lmax (Fig. 5 D).
In summary, a phosphorylation-dependent enhancement
in the binding interactions can produce the observed corre-
lation between the number of phosphorylation sites and re-
ceptor potency, and this enhancement is consistent with a
disorder-to-order transition upon phosphorylation that re-
duces the molecular entropic penalty to binding.DISCUSSION
Using cellular reconstitution, we have performed systematic
experiments to test predictions of mathematical models for
multisite phosphorylation as applied to the T cell receptor
z-chain. In contrast to model predictions, we have found
no evidence that multiple phosphorylation sites are able
to modulate the switchlike response but have found thatmultiple sites can modulate receptor potency and maximum
phosphorylation.
Reconstitution is a powerful reductionist method that en-
ables the study of a well-defined signaling module without
the feedbacks and unknown interactions that occur in native
cells. Hui and Vale (32) reconstituted the TCR z-chain with
different concentrations of Lck and CD45 on liposomes us-
ing purified proteins and found only a modest Hill number
of 2 that did not change when ZAP-70 was included, which
is consistent with our finding. James and Vale (30) reconsti-
tuted the TCR and a number of other TCR proximal compo-
nents in HEK293 cells to investigate the mechanism by
which ligand binding to the TCR induces intracellular phos-
phorylation, a process termed ‘‘TCR triggering’’ (16). In
contrast to their work, we did not find detectable basal phos-
phorylation when reconstituting the TCR, Lck, and CD148
alone in HEK293 cells. This discrepancy is likely a result of
the high expression of our extracellular domain truncated
phosphatase (38).
This work has several implications for TCR proximal
signaling. We have previously used a mathematical model
to show that multiple z-chain ITAMs, their sequential phos-
phorylation, and differences in ZAP-70 binding affinities
can generate emergent switchlike responses (14). However,
we found no evidence for sequential phosphorylation of the
TCR z-chain in this work. Two previous studies have pro-
vided evidence for sequential phosphorylation but differed
in the reported sequence (23,24). The discrepancy
with this work may be explained by the fact that the previ-
ous studies relied on measurements without systematic
variations to kinase/phosphatase. Moreover, we found no
evidence for in vivo differences in ZAP-70 binding affinities
in this work because, for example, the potencies of z-chainsBiophysical Journal 110, 1896–1906, April 26, 2016 1903
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ZAP-70 (Fig. 3 F). Previous work has suggested differences
in ZAP-70 binding affinities ranging from 3- to 30-fold
based on measurements with the isolated tandem SH2 do-
mains (31,39) but a more recent study has shown markedly
different behavior of the full protein (40). We have found
that ZAP-70 increases receptor potency but not the switch-
like response consistent with a previous study by Hui and
Vale (32). The combination of random phosphorylation
and similar ZAP-70 binding affinities predicts that multiple
ITAMs will not contribute to a switchlike response (see
Fig. 5A in Mukhopadhyay et al. (14)), which is the observa-
tion made in this work.
What is then the purpose of multiple ITAMs in the TCR
complex? Although the TCR z-chain ITAMs are not sequen-
tially phosphorylated, they may be involved in kinetic
proofreading, which relies on a delay (that can be produced
by either distributive sequential or distributive random phos-
phorylation) between initial ligand binding and downstream
signaling for antigen discrimination (18,20,41–46). The ef-
fect with the largest magnitude is the intuitive difference in
the maximum phosphorylation when ITAMs are removed.
This likely reflects the signal amplification property of the
TCR and is consistent with previous work showing that,
for example, T cell proliferation scales with the number,
but not the identity, of individual ITAMs (47) and more
recent work showing that the z-chain is dispensable for
many T cell responses (48). This leaves open the question
of why there are highly conserved differences in individual
ITAMs within the TCR (see, for example, Fig. S1 in Mukho-
padhyay et al. (14) for an alignment).
The observation that phosphorylation of one ITAM can
enhance the phosphorylation of other ITAMs is related to
the phenomenon termed ‘‘phosphorylation priming’’. Phos-
phoproteomic analysis revealed that phosphorylation of one
site can enhance the phosphorylation of neighboring sites
within ~10 amino acids (49). Moreover, recent studies
have found evidence for such phosphorylation priming in
an actin cross-linking protein (50) and within the two tyro-
sines of the ITAM (51).
The mechanism underlying phosphorylation priming is
incompletely understood. A possible mechanism is a disor-
der-to-order transition that phosphorylation may induce in
intrinsically disordered regions of proteins (33). The
T cell receptor z-chain, and indeed many noncatalytic tyro-
sine-phosphorylated receptors (52), have cytoplasmic tails
that are thought to be intrinsically disordered with a contin-
uum of states that can exhibit high molecular entropy. The
binding of a modifying enzyme to a disordered substrate in-
curs an entropic penalty because binding is often compatible
with only a subset of all states. If phosphorylation induces
local order, it may increase the effective on-rate for substrate
binding. We note that a switchlike response is not intro-
duced by this mechanism if it applies equally to both modi-
fying enzymes as we have implemented. But a switchlike1904 Biophysical Journal 110, 1896–1906, April 26, 2016response can be generated if, for example, the enhancement
applies selectively to one modifying enzyme or if the
reduced entropic binding allows the substrate to be seques-
tered away from both modifying enzymes (6,7,13).
Another mechanism that may explain phosphorylation
priming across ITAMs is the electrostatically mediated as-
sociation of the cytoplasmic tails of transmembrane recep-
tors with the membrane. Such interactions have been
demonstrated for the CD3E subunit of the TCR complex
(53,54), the TCR z-chain (25), and the ITIM-containing
receptor PECAM-1 (55). Because multisite phosphoryla-
tion drastically alters the charge of molecules it may
induce dissociation of the cytoplasmic tails from the mem-
brane. This mechanism can induce phosphorylation prim-
ing if the cytoplasmic tail becomes more accessible to the
modifying enzymes when dissociated from the membrane.
We note that published models of multisite phosphoryla-
tion have often reported switchlike responses, but not
changes in potency (8–15). Our previous work has shown
that local rebinding can lead to switchlike response when
diffusion is limited, but we did not observe a change in po-
tency (12).
Previous experimental work has reported switchlike re-
sponses by multisite phosphorylation that can apply to un-
structured proteins such as the TCR z-chain. For example,
phosphorylation has been shown to generate a switchlike
response in the membrane localization of the scaffold Ste5
by bulk electrostatics, whereby phosphorylation increases
the negative charge of the substrate and therefore leads
to reduced membrane association (56,57). As discussed
above, the association of the TCR z-chain with the mem-
brane is thought to be regulated by bulk electrostatics
(25,53). A key difference between Ste5 and the TCR is
that bulk electrostatics can completely alter the localization
of Ste5 whereas bulk electrostatics may only modestly alter
the average distance of the TCR cytoplasmic tails from the
membrane.
Although frequently responsible for switchlike responses
in other proteins, we have found that multisite phosphoryla-
tion of the TCR z-chain does not modulate the switchlike
response but can modulate the potency and maximum phos-
phorylation of the receptor. A key difference between the
TCR and other multisite substrates known to exhibit
switchlike responses is that phosphorylation sites in the
latter case are thought to act in concert. For example, in
the case of Ste5, Sic1, and NFAT, multiple phosphorylation
sites collectively regulate association with the membrane
(56,57), association with another protein (58), or a confor-
mational change (59,60), respectively. In contrast, the 10
ITAMs on the TCR can each independently provide docking
sites for the effector kinase ZAP-70, which can propagate
downstream signaling (20). In this way the TCR, and
possibly other immune receptors, have acquired multiple
phosphorylation sites that may individually act to amplify
ligand binding events.
Multisite z-Chain PhosphorylationSUPPORTING MATERIAL
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